APA (7th ed.) Citation

Abdellatif, A., Zhao, L., Obermeyer, K., Vranic, Z., Marder, B. A., & Scandling, J. D. Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: Findings of the phase 4 PROTECT clinical trial. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Abdellatif, Abdul, Lin Zhao, Katie Obermeyer, Zana Vranic, Brad A. Marder, and John D. Scandling. Quality of Life Improvements and Clinical Assessments in Kidney Transplant Recipients Undergoing Pegloticase Treatment for Uncontrolled Gout: Findings of the Phase 4 PROTECT Clinical Trial. Frontiers Media S.A.

MLA (9th ed.) Citation

Abdellatif, Abdul, et al. Quality of Life Improvements and Clinical Assessments in Kidney Transplant Recipients Undergoing Pegloticase Treatment for Uncontrolled Gout: Findings of the Phase 4 PROTECT Clinical Trial. Frontiers Media S.A.